Experimental Drug, Ianalumab, Provides Lasting Relief For Bleeding Condition
Published on December 12, 2025 at 04:42PM by Drugs.com - Daily MedNews
FRIDAY, Dec. 12, 2025 — More than half of people with a rare life-threatening bleeding condition received lasting relief from an experimental antibody treatment, clinical trial results show. Ianalumab, a monoclonal antibody, helped patients...
Read the original article here: https://www.drugs.com/news/experimental-ianalumab-provides-lasting-relief-bleeding-condition-127932.html